GlassScriptPhysician profile
Sonja J Tiller
NPI 1427449529
$2,041.65
in general payments reported to CMS, 2019-2025
17 companies · $449 in 2025
The $449 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $521 · 2022: $522 · 2023: $423 · 2024: $127 · 2025: $449.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $999.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $998.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $314.55 | 2022-2025 | Austedo Xr, Austedo |
| Amgen INC. | $308.14 | 2021-2024 | |
| Neurocrine Biosciences, INC. | $217.46 | 2023-2025 | Ingrezza |
| Jazz Pharmaceuticals INC. | $199.69 | 2021 | |
| Ars Pharmaceuticals Operations, INC. | $126.27 | 2025 | Neffy |
| Forte Bio-Pharma LLC | $125.01 | 2025 | Prolate, Tanlor, Nalocet |
| Boston Scientific Corporation | $121.23 | 2023 | Watchman |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $116.53 | 2021 | |
| Genentech USA, INC. | $95.36 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $91.97 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $84.88 | 2022 | |
| Coloplast Corp | $66.66 | 2022 | |
| Avanos Medical | $58.15 | 2023 | On-Q* Pump and Accessories |
| Nevro Corp. | $54.76 | 2022 | |
| Gilead Sciences, INC. | $22.01 | 2023 | Trodelvy |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $21.93 | 2021 | |
| Nabriva Therapeutics, Plc | $17.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonja Tiller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.